- Home
- APLT vs AMSC Comparison
APLT vs AMSC Comparison
Compare APLT & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | AMSC |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 1.5B |
| IPO Year | 2019 | 1991 |
Fundamental Metrics
Financial Performance| Metric | APLT | AMSC |
|---|---|---|
| Price | $0.12 | $29.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $1.25 | ★ $45.50 |
| AVG Volume (30 Days) | ★ 10.5M | 815.3K |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $1,000,000.00 | ★ $266,277,000.00 |
| Revenue This Year | $124.18 | $26.27 |
| Revenue Next Year | $66.67 | $8.91 |
| P/E Ratio | ★ N/A | $82.86 |
| Revenue Growth | N/A | ★ 51.17 |
| 52 Week Low | $0.10 | $13.98 |
| 52 Week High | $1.50 | $70.49 |
Technical Indicators
Market Signals| Indicator | APLT | AMSC |
|---|---|---|
| Relative Strength Index (RSI) | 25.84 | 31.64 |
| Support Level | $0.10 | $30.27 |
| Resistance Level | $0.26 | $32.59 |
| Average True Range (ATR) | 0.02 | 1.57 |
| MACD | 0.01 | 0.73 |
| Stochastic Oscillator | 12.08 | 5.12 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.